ARDS - Aridis Pharmaceuticals GAAP EPS of -$0.44 beats by $0.07 revenue of $1.18M misses by $0.82M May, 16 2022 04:34 PM Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals press release (NASDAQ:ARDS): Q1 GAAP EPS of -$0.44 beats by $0.07. Revenue of $1.18M misses by $0.82M. For further details see: Aridis Pharmaceuticals GAAP EPS of -$0.44 beats by $0.07, revenue of $1.18M misses by $0.82M